D
Esperion Therapeutics, Inc. ESPR
$1.50 $0.000.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 185.66% 187.12% 215.98% 183.74% 54.14%
Total Other Revenue -- -- -- -- --
Total Revenue 185.66% 187.12% 215.98% 183.74% 54.14%
Cost of Revenue -11.23% -21.80% -25.39% -30.27% -11.32%
Gross Profit 1,767.75% 645.46% 398.67% 256.73% 81.48%
SG&A Expenses 14.42% 41.52% 45.93% 42.36% 30.66%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 2.21% 7.88% 5.87% -0.62% 6.64%
Operating Income 134.97% 110.57% 102.91% 81.26% 13.34%
Income Before Tax 75.27% 58.36% 55.68% 63.75% 10.45%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 75.27% 58.36% 55.68% 63.75% 10.45%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 75.27% 58.36% 55.68% 63.75% 10.45%
EBIT 134.97% 110.57% 102.91% 81.26% 13.34%
EBITDA 135.07% 110.63% 102.97% 81.28% 13.19%
EPS Basic 89.21% 73.80% 70.22% 71.60% 40.41%
Normalized Basic EPS 102.95% 85.75% 80.27% 71.64% 40.22%
EPS Diluted 88.06% 72.79% 69.37% 70.90% 40.32%
Normalized Diluted EPS 101.12% 84.12% 78.89% 70.50% 40.22%
Average Basic Shares Outstanding 81.71% 78.37% 77.01% 77.68% 55.18%
Average Diluted Shares Outstanding 86.65% 83.83% 83.21% 84.89% 55.18%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings